BIOHENG
BioHeng is a clinical biopharmaceutical and biotechnology Company focuses on novel immunotherapy and next-generation gene therapy development for treating cancers and various diseases. Founded in 2017, Bioheng has established a high standard GMP grade clinical translational center, and is leading in the field of cell engineering, proliferation and clinical applications. Particularly, Bioheng owns several cutting-edge patents plus extensive industry experience, and has built a complete, closed an... d automated production system in compliance with regulatory guidelines. In 2018, Bioheng has successfully raised tens of millions of RMB seeding fund from Simcere Pharmaceutical Group, aiming to accelerate the development of immunotherapy via integrating resources from both parties. Bioheng is dedicated to develop safer, effective and less expensive cell therapy drugs to benefit more patients.
BIOHENG
Industry:
Biopharma Biotechnology Clinical Trials Health Care Innovation Management
Founded:
2017-01-01
Address:
Nanjing, Jiangsu, China
Country:
China
Website Url:
http://www.bioheng.com
Total Employee:
1+
Status:
Active
Contact:
400-828-8076
Email Addresses:
[email protected]
Total Funding:
620 M CNY
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Mobile Non Scaleable Content Apple Mobile Web App Capable JQuery CDN Apple Mobile Web App Status Bar Style Cart Functionality HiChina DNS
Similar Organizations
Hangzhou Just Biotherapeutics (Just China)
Hangzhou Just Biotherapeutics is a comprehensive high-tech design company.
IFTech
IFTech Inventing Future Technology Inc. is a high tech innovation company.
Qihan Biotech
Qihan Biotech is a gene-editing organ transplantation technology developer.
Themis Bioscience
Themis Bioscience is a start-up biotechnology company.
YS Biopharma
YS Biopharma is a global, fully integrated bio-pharmaceutical company.
Current Employees Featured
Founder
Investors List
Hillhouse Capital Group
Hillhouse Capital Group investment in Series B - Bioheng
Octagon Capital Partners
Octagon Capital Partners investment in Series B - Bioheng
Decheng Capital
Decheng Capital investment in Series B - Bioheng
GL Ventures
GL Ventures investment in Series B - Bioheng
BlueRun Ventures
BlueRun Ventures investment in Series B - Bioheng
Min Cui
Min Cui investment in Series B - Bioheng
Shenzhen Capital Group
Shenzhen Capital Group investment in Series B - Bioheng
Decheng Capital
Decheng Capital investment in Series A - Bioheng
Official Site Inspections
http://www.bioheng.com
- Host name: 123.59.154.172
- IP address: 123.59.154.172
- Location: Beijing China
- Latitude: 39.9288
- Longitude: 116.3889
- Timezone: Asia/Shanghai
More informations about "Bioheng"
Bioheng Therapeutics-CAR-T,UCAR-T
Bioheng Therapeutics is a clinical-stage company focused on allogeneic " off-the-shelf " universal CAR-T therapies. Founded in 2017, we aim to develop the world’s leading allogeneic cell …See details»
Bioheng - Crunchbase Company Profile & Funding
BioHeng is a clinical biopharmaceutical and biotechnology Company focuses on novel immunotherapy and next-generation gene therapy development for treating cancers and various diseases. Founded in 2017, Bioheng has established a …See details»
Bioheng Therapeutics - LinkedIn
Bioheng Therapeutics is a clinical stage company focused on allogeneic / off-the-shelf CAR-T. Founded in 2017, we aim to develop the world's leading allogeneic cell therapy products to …See details»
Bioheng Company Profile - Office Locations, Competitors ... - Craft
Bioheng (also known as Nanjing Beiheng Biotech, 北恒生物) is a biopharmaceutical company that focuses on immunotherapy and gene therapy for treating cancer. It also provides a range of …See details»
Bioheng - Funding, Financials, Valuation & Investors - Crunchbase
Bioheng is a high-tech R&D innovation company. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. Resources. Log In. Organization. ... How …See details»
BioHeng - Company Profile - Tracxn
Dec 14, 2024 BioHeng. has raised a total funding of $105M over 4 rounds. Its first funding round was on Feb 14, 2019. What are the most recent funding rounds of BioHeng? Its latest funding …See details»
Nanjing Bioheng Biotech Co., Ltd.
Explore Nanjing Bioheng Biotech Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 18 clinical trials, 8 news, and 2 literature, Disease Domain:Neoplasms, Hemic and …See details»
Science & Products-Bioheng Therapeutics
Bioheng Therapeutics Science & Products Bioheng Therapeutics is a clinical stage company focused on allogeneic / off-the-shelf CAR-T. About. About Bioheng. History. Science & Products. Pipelines. Technology Platforms. …See details»
Contact-Bioheng Therapeutics
Bioheng Therapeutics Contact Bioheng Therapeutics is a clinical stage company focused on allogeneic / off-the-shelf CAR-T. About. About Bioheng. History. Science & Products. …See details»
Bioheng Biotech - VentureRadar
" Bioheng is a clinical-stage biotech company focusing on the development and commercialization of novel allogeneic cellular immunotherapy for immediate treatment to cancer patients, which …See details»
南京北恒生物科技有限公司_www.bioheng.com
Dec 21, 2024 南京北恒生物科技有限公司：公司成立于2017年，是一家专注于通用型细胞免疫治疗（UCAR-T）产品开发及商业化的创新型生物科技公司。公司现成功开发通用型CAR-T细胞 …See details»
Nanjing Bioheng Biotech Co., Ltd. - synapse.zhihuiya.com
了解Nanjing Bioheng Biotech Co., Ltd. (南京北恒生物科技有限公司)公司的药物管线，治疗领域，技术平台，以及它的18项临床试验, 15篇新闻和2篇文献，疾病领域:肿瘤，免疫系统疾病， …See details»
Bioheng Therapeutics Company Profile 2024: Valuation, Funding ...
Bioheng Therapeutics has raised $94.8M. Who are Bioheng Therapeutics’s investors? Hillhouse Investment Group , Lanchi Ventures , Octagon Capital Advisors , Shenzhen Capital Group , …See details»
Bioheng - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Bioheng . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. Bioheng has 1 …See details»
Bioheng - Products, Competitors, Financials, Employees, …
Bioheng is a biopharmaceutical company focusing on the development and commercialization of disease treatment products. Use the CB Insights Platform to explore Bioheng's full profile. ...See details»
Bioheng Company Profile: Overview and Full News Analysis
Bioheng is a biopharmaceutical company located in Jiangsu, China, specializing in the development and commercialization of innovative disease treatment products. Established in …See details»
Company: Bioheng Biotech
Bioheng Biotech is a Chinese clinical stage biotech company. The company's main focus is on developing CAR-T cells for the treatment of T-cell cancers. The company is using its …See details»
Bioheng Raised $80 Million in Series B Financing to Advance …
NANJING, China, March 24, 2021 /PRNewswire/ -- Bioheng Biotech Co., Ltd, a clinical-stage biotechnology company dedicated on developing novel cellular immunotherapy for cancer, …See details»
Bioheng Announced Oral Presentation of Its Preliminary Results of ...
NANJING, China, Nov. 10, 2020 -- Bioheng Biotech Co., Ltd, a clinical-stage biotech company focused on developing novel cellular immunotherapy to treat cancer, today announced an oral …See details»
News-Bioheng Therapeutics
Bioheng's CD7 UCAR-T and Allogeneic HSCT Sequential Therapy Study Published in the New England Journal of Medicine On April 25, 2024, The New England Journal of Medicine …See details»